Method Peptides · Research compound

SLU-PP-332

$70.00
Dose: 1 mg
≥99% purity
Third-party tested
Ships from the USA
Secure, discreet packaging
ShippingFree on orders $200+

$15 flat rate on orders under $200.

FulfillmentEstimated 2–5 business days

Tracking is provided when the order ships.

Review return policy →

Research reference

Compound overview

Product specifications, research context, and handling information.

SLU-PP-332

SLU-PP-332 is a synthetic small molecule studied as an agonist of estrogen-related receptors ERRα, ERRβ, and ERRγ.

Cellular and animal studies examine oxidative metabolism, mitochondrial gene expression, and energy utilization. These findings do not establish performance or metabolic outcomes for this product. This listing supplies a capsule formulation; compound content and capsule count are specified below.

Key Research Areas

  • ERR receptor pharmacology
  • Mitochondrial gene expression
  • Oxidative-metabolism models
  • Cellular energy utilization

Mechanism of Interest

SLU-PP-332 activates ERR nuclear receptors, with activity reported across all three subtypes. These receptors regulate transcriptional programs associated with energy metabolism; they are distinct from estrogen receptors and PPARs.

Product Details

Format: Capsules; 60 per bottle
Compound Content: 1 mg per capsule
Total Compound: 60 mg per bottle
Compound Class: Small molecule; estrogen-related receptor agonist
Compound: SLU-PP-332
Storage: Store in a cool, dry place protected from light and moisture; follow product labeling.

Metabolism at the Gene Level

Estrogen-related receptors help regulate genes involved in mitochondrial function and energy use. SLU-PP-332 research examines how activating these receptors changes oxidative metabolism in cellular and preclinical animal models.

Research Use Only:

This product is intended strictly for laboratory and research purposes. Not for human consumption, medical use, diagnostic use, or therapeutic use.